SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fortis Healthcare surges on redeeming $100 million FCCBs

25 May 2015 Evaluate

Fortis Healthcare is currently trading at Rs. 171.40, up by 1.65 points or 0.97% from its previous closing of Rs. 169.75 on the BSE.

The scrip opened at Rs. 170.30 and has touched a high and low of Rs. 174.65 and Rs. 168.25 respectively. So far 148039 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 184.50 on 13-Apr-2015 and a 52 week low of Rs. 100.50 on 16-Dec-2014.

Last one week high and low of the scrip stood at Rs. 174.65 and Rs. 159.50 respectively. The current market cap of the company is Rs. 7926.83 crore.

The promoters holding in the company stood at 71.34% while Institutions and Non-Institutions held 8.91% and 19.75% respectively.

Fortis Healthcare has redeemed the outstanding $100 million FCCBs listed on the Luxembourg stock exchange, on the due date. The company had originally raised the FCCBs in the year 2010. The total payout for the outstanding bonds was $105.67 million including the redemption premium of approximately $3.17 million and the interest payment of $2.5 million for the preceding 6 month period ending May 21, 2015. The redemption was made from the existing cash proceeds of the company.

Post the redemption of the FCCBs, the company’s net debt to equity ratio is estimated to be less than 0.15x as against 0.27x as on December 31, 2014.

Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 9 countries.

 

Fortis Healthcare Share Price

889.75 15.45 (1.77%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×